Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP752166.RAT1F_662W2pjJEpWaZJmfilmJImfF0PMhfTTaJMv6VcM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP752166.RAT1F_662W2pjJEpWaZJmfilmJImfF0PMhfTTaJMv6VcM130_assertion type Assertion NP752166.RAT1F_662W2pjJEpWaZJmfilmJImfF0PMhfTTaJMv6VcM130_head.
- NP752166.RAT1F_662W2pjJEpWaZJmfilmJImfF0PMhfTTaJMv6VcM130_assertion description "[In vitro, Zyflamend inhibited the proliferation of pancreatic cancer cell lines regardless of p53 status and also enhanced gemcitabine-induced apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP752166.RAT1F_662W2pjJEpWaZJmfilmJImfF0PMhfTTaJMv6VcM130_provenance.
- NP752166.RAT1F_662W2pjJEpWaZJmfilmJImfF0PMhfTTaJMv6VcM130_assertion evidence source_evidence_literature NP752166.RAT1F_662W2pjJEpWaZJmfilmJImfF0PMhfTTaJMv6VcM130_provenance.
- NP752166.RAT1F_662W2pjJEpWaZJmfilmJImfF0PMhfTTaJMv6VcM130_assertion SIO_000772 21935918 NP752166.RAT1F_662W2pjJEpWaZJmfilmJImfF0PMhfTTaJMv6VcM130_provenance.
- NP752166.RAT1F_662W2pjJEpWaZJmfilmJImfF0PMhfTTaJMv6VcM130_assertion wasDerivedFrom befree-20150227 NP752166.RAT1F_662W2pjJEpWaZJmfilmJImfF0PMhfTTaJMv6VcM130_provenance.
- NP752166.RAT1F_662W2pjJEpWaZJmfilmJImfF0PMhfTTaJMv6VcM130_assertion wasGeneratedBy ECO_0000203 NP752166.RAT1F_662W2pjJEpWaZJmfilmJImfF0PMhfTTaJMv6VcM130_provenance.